Concept of Crohn's disease being conditioned by four main components, and irritable bowel syndrome being an incomplete Crohn's disease

References

• Sachar DB. Crohn's disease: a family affair. Gastroenterology 1996; 111: 813–5
   PubMedGoogle Scholar
• Watanabe T, Kitani A, Murray PJ, Strober W. NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nature Immunology 2004; 5: 800–8
   PubMed Web of Science ®Google Scholar
• Wehkamp J, Harder J, Weichenthal M, Schwab M, Schäffeler E, Sclee M, et al. NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal α-defensin expression. Gut 2004; 53: 1658–64
   PubMed Web of Science ®Google Scholar
• Buhner S, Buning C, Genschel J, Kling K, Hermann D, Dignass A, et al. Genetic basis for increased intestinal permeability in families with Crohn's disease: role of CARD15 3020insC mutation?. Gut 2006; 55: 342–7
   PubMed Web of Science ®Google Scholar
• Wyatt J, Vogelsang H, Hubl W, Waldhoer T, Lochs H. Intestinal permeability and the prediction of relapse in Crohn's disease. Lancet 1993; 341: 1437–9
   PubMed Web of Science ®Google Scholar
• Arnott ID, Kingstone K, Ghosh S. Abnormal intestinal permeability predicts relapse in inactive Crohn disease. Scand J Gastroenterol 2000; 35: 1163–9
   PubMed Web of Science ®Google Scholar
• May GR, Sutherland LR, Meddings JB. Is small intestinal permeability really increased in relatives of patients with Crohn's disease?. Gastroenterology 1993; 104: 1627–32
   PubMed Web of Science ®Google Scholar
• Hilsden RJ, Meddings JB, Sutherland LR. Intestinal permeability changes in response to acetylsalicylic acid in relatives of patients with Crohn's disease. Gastroenterology 1996; 110: 1395–403
   PubMed Web of Science ®Google Scholar
• Söderholm JD, Olaison G, Lindberg E, Hannestad U, Vindels A, Tysk C, et al. Different intestinal permeability patterns in relatives and spouses of patients with Crohn's disease: an inherited defect in mucosal defence?. Gut 1999; 44: 96–100
   PubMed Web of Science ®Google Scholar
• Rutgeerts P, Goboes K, Peeters M, Hiele M, Penninckx F, Aerts R, et al. Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum. Lancet 1991; 338: 771–4
   PubMed Web of Science ®Google Scholar
• Harper PH, Truelove SC, Lee ECG, Kettlewell MGW, Jewell DP. Split ileostomy and ileocolostomy for Crohn's disease of the colon and ulcerative colitis. Gut 1983; 24: 106–13
   PubMed Web of Science ®Google Scholar
• Elson CO, Layden TJ, Nemchausky BA, Rosenberg JL, Rosenberg IH. An evaluation of total parenteral nutrition in the management of inflammatory bowel disease. Dig Dis Sci 1980; 25: 42–8
   PubMedGoogle Scholar
• Kushner RF, Shapir J, Sitrin MD. Endoscopic, radiographic, and clinical response to prolonged bowel rest and home parenteral nutrition in Crohn's disease. J Parenter Enteral Nutr 1986; 10: 568–73
   PubMed Web of Science ®Google Scholar
• Wright RA, Adler EC. Peripheral parenteral nutrition is no better than enteral nutrition in acute exacerbation of Crohn's disease: a prospective trial. J Clin Gastroenterol 1990; 12: 396–9
   PubMed Web of Science ®Google Scholar
• Harper PH, Lee EC, Kettlewell MG, Bennett MK, Jewell DP. Role of the faecal stream in the maintenance of Crohn's colitis. Gut 1985; 26: 279–84
   PubMed Web of Science ®Google Scholar
• Fasoli R, Kettlewell MGW, Mortensen N, Jewell DP. Response to faecal challenge in defunctioned colonic Crohn's disease: prediction of long-term course. Br J Surg 1990; 77: 616–7
   PubMedGoogle Scholar
• D'Haens GR, Geboes K, Peeters M, Baert F, Penninckx F, Rutgeerts P. Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology 1998; 114: 262–7
   PubMed Web of Science ®Google Scholar
• Peeters M, Ghoos Y, Maes B, Hiele M, Geboes K, Vantrappen G, et al. Increased permeability of macroscopically normal small bowel in Crohn's disease. Dig Dis Sci 1994; 39: 2170–6
   Google Scholar
• Peeters M, Geypens B, Claus D, Nevens H, Ghoos Y, Verbeke G, et al. Clustering of increased small intestinal permeability in families with Crohn's disease. Gastroenterology 1997; 113: 802–7
   PubMed Web of Science ®Google Scholar
• Breslin NP, Nash C, Hilsden RJ, Hershfield NB, Price LM, Meddings JB, et al. Intestinal permeability is increased in a proportion of spouses of patients with Crohn's disease. Am J Gastroenterol 2001; 96: 2934–8
   PubMed Web of Science ®Google Scholar
• Irvine EJ, Marshall JK. Increased intestinal permeability precedes the onset of Crohn's disease in a subject with familial risk. Gastroenterology 2000; 119: 1740–4
   PubMed Web of Science ®Google Scholar
• Adenis A, Colombel JF, Lecouffe P. Increased pulmonary and intestinal permeability in Crohn's disease. Gut 1992; 33: 678–82
   PubMed Web of Science ®Google Scholar
• Suzuki N, Yoshida A, Nakano Y. Quantitative analysis of multi-species oral biofilms by TaqMan real-time PCR. Clin Med Res 2005; 3: 176–85
   PubMedGoogle Scholar
• Birrenbach T, Böcker U. Inflammatory bowel disease and smoking: a review of epidemiology, pathophysiology, and therapeutic implications. Inflamm Bowel Dis 2004; 10: 848–59
   PubMed Web of Science ®Google Scholar
• Kane SV, Flicker M, Katz-Nelson F. Tobacco use is associated with accelerated clinical recurrence of Crohn's disease after surgically induced remission. J Clin Gastroenterol 2005; 39: 32–5
   PubMed Web of Science ®Google Scholar
• van Winkelhoff AJ, Bosch-Tijhof CJ, Winkel EG, van der Reijden WA. Smoking affects the subgingival microflora in periodontitis. J Periodontol 2001; 72: 666–71
   PubMed Web of Science ®Google Scholar
• Ertel A, Eng R, Smith SM. The differential effect of cigarette smoke on the growth of bacteria found in humans. Chest 1991; 100: 628–30
   PubMed Web of Science ®Google Scholar
• Suenaert P, Bulteel V, den Hond E, Hiele M, Peeters M, Monsuur F, et al. The effects of smoking and indomethacin on small intestinal permeability. Aliment Pharmacol Ther 2000; 14: 819–822
   PubMed Web of Science ®Google Scholar
• Gotteland M, Cruchet S, Frau V, Wegner ME, Lopez R, Herrera T. Effect of acute cigarette smoking, alone or with alcohol, on gastric barrier function in healthy volunteers. Dig Liver Dis 2002; 34: 702–6
   PubMedGoogle Scholar
• Püspök A, Oberhuber G, Wyatt J, Maier-Dobersberger T, Hammer J, Pfeffel F, et al. Gastroduodenal permeability in Crohn's disease. Eur J Clin Invest 1998; 28: 67–71
   PubMedGoogle Scholar
• Weinstein WM. Emerging gastritides. Curr Gastroenterol Rep 2001; 3: 523–7
   PubMedGoogle Scholar
• Mottet C, Juillerat P, Gonvers JJ, Michetti P, Burnand B, Vader JP, et al. Treatment of gastroduodenal Crohn's disease. Digestion 2005; 71: 37–40
   PubMedGoogle Scholar
• Halme L, Karkkainen P, Rautelin H, Kosunen T, Sipponen P. High frequency of Helicobacter negative gastritis in patients with Crohn's disease. Gut 1996; 38: 379–83
   PubMed Web of Science ®Google Scholar
• Vare PO, Heikius B, Sivennoinen JA, Karttunen R, Niemala SE, Lehtola JK, et al. Seroprevalence of Helicobacter pylori infection in inflammatory bowel disease: is Helicobacter pylori infection a protective factor?. Scand J Gastroenterol 2001; 36: 295–300
   Google Scholar
• Mitic LL, van Itallie CM, Anderson JM. Molecular physiology and pathophysiology of tight junctions I. Tight junction structure and function: lessons from mutant animals and proteins. Am J Physiol Gastrointest Liver Physiol 2000; 279: G250–4
   PubMed Web of Science ®Google Scholar
• Fassano A. Intestinal zonulin: open sesame!. Gut 2001; 49: 159–62
   PubMedGoogle Scholar
• Nejdfors P, Ekelund M, Jeppsson B, Weström BR. Mucosal in vitro permeability in the intestinal tract of the pig, the rat, and man: species- and region-related differences. Scand J Gastroenterol 2000; 35: 501–7
   PubMed Web of Science ®Google Scholar
• Darfeuille-Michaud A, Neut C, Barnich N, Lederman E, di Martino P, Desreumaux P, et al. Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology 1998; 115: 1405–13
   PubMed Web of Science ®Google Scholar
• Martin HM, Campbell BJ, Hart CA, Mpofu C, Nayar M, Singh R, et al. Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer. Gastroenterology 2004; 127: 80–93
   PubMed Web of Science ®Google Scholar
• Ambrose NS, Johnson M, Burdon DW, Keigley RB. Incidence of pathogenic bacteria from mesenteric lymph nodes and ileal serosa during Crohn's disease surgery. Br J Surg 1984; 71: 623–5
   PubMed Web of Science ®Google Scholar
• Darfeuille-Michaud A, Boudeau J, Bulois P, Neut C, Glasser AL, Barnich N, et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 2004; 127: 412–21
   PubMed Web of Science ®Google Scholar
• Söderholm JD, Streutker C, Yang PC, Paterson C, Singh PK, McKay DM, et al. Increased epithelial uptake of protein antigens in the ileum of Crohn's disease mediated by tumour necrosis factor alpha. Gut 2004; 53: 1817–24
   PubMed Web of Science ®Google Scholar
• Sanderson JD, Moss MT, Tizard MLV, Hermon-Taylor J. Mycobacterium paratuberculosis DNA in Crohn's disease tissue. Gut 1992; 33: 890–6
   PubMed Web of Science ®Google Scholar
• Hulten K, El-Zimaity HMT, Karttunen TJ, Almashhrawi A, Schwartz MR, Graham DY, et al. Detection of Mycobacterium avium subspecies paratuberculosis in Crohn's disease tissues by in situ hybridization. Am J Gastroenterol 2001; 96: 1529–35
   PubMedGoogle Scholar
• Quinton JF, Sendid B, Reumaux D, Duthille P, Cortot A, Grandbastien B, et al. Anti-Saccharomyces cerevisiae mamman antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut 1998; 42: 788–91
   PubMed Web of Science ®Google Scholar
• Sutton CL, Yang H, Li Z, Rotter JI, Targan SR, Braun J. Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in affected and unaffected relatives of patients with Crohn's disease. Gut 2000; 46: 58–63
   PubMed Web of Science ®Google Scholar
• Landers CJ, Cohavy O, Misra R, Yang H, Lin Y-C, Braun J, et al. Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens. Gastroenterology 2002; 123: 689–99
   PubMed Web of Science ®Google Scholar
• Mow WS, Vasiliauskas EA, Lin Y-C, Fleshner PR, Papadakis KA, Taylor KD, et al. Association of antibody responses to microbial antigens and complications of small-bowel Crohn's disease. Gastroenterology 2004; 126: 414–25
   PubMed Web of Science ®Google Scholar
• Mawdsley JE, Rampton DS. Psychological stress in IBD: new insight into pathogenic and therapeutic implications. Gut 2005; 54: 1481–91
   PubMed Web of Science ®Google Scholar
• Jacob C, Yang P-C, Darmoul D, Amadesi S, Saito T, Cottrell GS, et al. Mast cell tryptase controls paracellular permeability of the intestine. J Biol Chem 2005; 280: 31936–48
   PubMed Web of Science ®Google Scholar
• Lacy BE, Lee RD. Irritable bowel syndrome: a syndrome in evolution. J Clin Gastroenterol 2005; 39(Suppl 3)S230–42
   Google Scholar
• Spiller RC. Postinfectious irritable bowel syndrome. Gastroenterology 2003; 124: 1662–71
   PubMed Web of Science ®Google Scholar
• Minderhoud IM, Oldenburg B, Wismeijer JA, van Berge Henegouwen GP, Smout AJ. IBS-like symptoms in patients with inflammatory bowel disease in remission; relationships with quality of life and coping behavior. Dig Dis Sci 2004; 49: 469–74
   PubMed Web of Science ®Google Scholar
• Bouin M, Plourde V, Boivin M, Riberdy M, Lupien F, Laganière M, et al. Rectal distention testing in patients with irritable bowel syndrome: sensitivity, specificity, and predictive values of pain sensory thresholds. Gastroenterology 2002; 122: 1771–7
   PubMed Web of Science ®Google Scholar
• Kuiken SD, Lindeboom R, Tytgat GN, Boeckxstaens GE. Relationship between symptoms and hypersensitivity to rectal distension in patients with irritable bowel syndrome. Aliment Pharmacol Ther 2005; 22: 157–64
   PubMed Web of Science ®Google Scholar
• Spiller R, Campbell E. Post-infectious irritable bowel syndrome. Curr Opin Gastroenterol 2006; 22: 13–7
   PubMed Web of Science ®Google Scholar
• Törnblom H, Lindberg G, Nyberg B, Veress B. Full-thickness biopsy of the jejunum reveals inflammation and enteric neuropathy in irritable bowel syndrome. Gastroenterology 2002; 123: 1972–9
   PubMed Web of Science ®Google Scholar
• Chadwick VS, Chen W, Shu D, Paulus B, Bethwate P, Tie A, et al. Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology 2002; 122: 1778–83
   PubMed Web of Science ®Google Scholar
• Spiller R, Jenkins D, Thornley JP, Hebden JM, Wright T, Skinner M, et al. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 2000; 47: 804–11
   PubMed Web of Science ®Google Scholar
• Marshall JK, Thabane M, Garg AX, Clark W, Meddings J, Collins SM. Intestinal permeability in patients with irritable bowel syndrome after a waterborne outbreak of acute gastroenteritis in Walkerton, Ontario. Aliment Pharmacol Ther 2004; 20: 1317–22
   PubMed Web of Science ®Google Scholar
• Dunlop SP, Hebden J, Naesdal J, Olbe L, Perkins C, Spiller RC. Abnormal intestinal permeability in subgroups of diarrhoea-predominant irritable bowel syndromes. Am J Gastroenterology 2006; 101: 1288–94
   PubMed Web of Science ®Google Scholar
• García Rodríguez LA, Ruigómez A, Wallander M-A, Johansson S, Olbe L. Detection of colorectal tumor and inflammatory bowel disease during follow-up of patients with initial diagnosis of irritable bowel syndromes. Scand J Gastroenterol 2000; 35: 306–11
   PubMed Web of Science ®Google Scholar